Venkata Jakkampudi, MD
Clinical Neurophysiology · Hershey, PANPI 1396754701
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,914 of the $6,581 with a category attached, or 74.7%. It is spread thinly across 15 manufacturers, the largest accounting for just 19.2%. Reporting peaked in 2019 at $3,079 and has fallen 94.4% since, to $173 in 2025.
Across 71 payments — averaging $92.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Boston Scientific$1K
- AbbVie$792
- Acadia Pharmaceuticals Inc$617
- Biogen$516
- Greenwich Biosciences, Inc.$465
- plus $2K from 9 others
What the payments were for
- Consulting fees$78012%
- Travel & lodging$88713%
- Food & beverage$4,91475%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 11 | $1,263 |
| Boston Scientific | 9 | $1,178 |
| AbbVie(2 entities) | 13 | $792 |
| Acadia Pharmaceuticals Inc | 8 | $617 |
| Biogen | 5 | $516 |
| Greenwich Biosciences, Inc. | 5 | $465 |
| Biohaven Pharmaceuticals, Inc. | 5 | $446 |
| Neurocrine Biosciences, Inc. | 3 | $354 |
| AstraZeneca | 4 | $334 |
| E.r. Squibb & Sons, L.L.C. | 2 | $190 |
| SK Life Science, Inc. | 2 | $100 |
| Amgen | 1 | $96 |
| Kyowa Kirin, Inc. | 1 | $77 |
| EMD Serono, Inc. | 1 | $77 |
| Abbott | 1 | $76 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL DBS$1,030
- ACTIVA$993
- NUPLAZID$357
- INGREZZA$354
- BOTOX$262
- Epidiolex$129
- NURTEC ODT$125
- SenSight$122
How this compares
Too few clinical neurophysiology providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RytaryCarbidopa/Levodopa | 17 | $25,582 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 38 | $2,062 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 34 | $1,516 |
| AmantadineAmantadine Hcl | 14 | $899 |
| Donepezil Hcl | 36 | $817 |
| Primidone | 13 | $546 |
Paid to pharmacies, not to this prescriber.
Other clinical neurophysiology in Hershey
- Zachary SimmonsHershey$43K
- Saira SaadHarrisburg$48K
- Sandeep RanaPittsburgh$30K
- Venkatraman ThulasiBethlehem$29K
- Sonya KnightBlue Bell$19K
- Charles BaePhiladelphia$7K
- Jagdish ShahMechanicsburg$3K
- Laxmi ShahMonroeville$2K
- Cynthia CorrellDanville$2K
- Karen CarvalhoPhiladelphia$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.